Nanobiotix Sa - Adr Share Price

NASDAQ: NBTX

Small Cap

$9.74

+0.42

(+4.51%)

as on September 17, 2025 at 1:29 am IST

$₹

Nanobiotix Sa - Adr Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$9.72
Day's Price Range
$10.22
$9.74
0.21%
Downside
4.93%
Upside
52 Week's Low
52 Week's High
$2.76
52-Week Price Range
$10.59
$9.74
71.66%
Downside
8.73%
Upside

Nanobiotix Sa - Adr share price movements today

Previous Close: $9.32
Open: $9.72
Volume: 1.7M
Day's Low - High: $9.72 - $10.22
52 Week Low - High: $2.76 - $10.59

Nanobiotix Sa - Adr Historical Returns

1 Month Return: + 17.82 %
3 Month Return: + 86.77 %
1 Year Return: + 89.04 %
3 Year Return: + 112.78 %
5 Year Return: 0 %

Nanobiotix Sa - Adr Stock Fundamentals & Key Indicators

Check Nanobiotix Sa - Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$480.2M

EPS (TTM)

-0.6926

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-67.7M

Revenue (TTM)

-7.2M

Profit Margin

0.00%

Return On Equity TTM

2611700.00%

Nanobiotix Sa - Adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nanobiotix Sa - Adr with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Nanobiotix Sa - Adr	BUY	$480.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Nanobiotix Sa - Adr Stock including INR - Dollar returns

The Nanobiotix Sa - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Nanobiotix Sa - Adr investment value today

Current value as on today

₹2,02,433

Returns

₹1,02,433

(+102.43%)

Returns from Nanobiotix Sa - Adr Stock

₹97,566 (+97.57%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Nanobiotix Sa - Adr Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Nanobiotix Sa - Adr. Average target price of $7.69

Nanobiotix Sa - Adr Share Price Target

Get share price movements and forecasts by analysts on Nanobiotix Sa - Adr.

What analysts predicted

-26.66%DOWNSIDE

Target Price

$7.69

Current Price

$9.74

Analyzed by

10 Analysts

Target

$7.69

Nanobiotix Sa - Adr target price $7.69, a slight downside of -26.66% compared to current price of $9.74. According to 10 analysts rating.

Nanobiotix Sa - Adr Stock's Interest Amongst Investors

Search interest for Nanobiotix Sa - Adr Stock has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-27% versus previous 30 day period

Nanobiotix Sa - Adr Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Mar 2025
Total Revenue	0	0	1	1	3	16	32	9	-20
Gross Profit	0	0	1	1	3	16	32	9	-20
Operating Income	-24	-26	-10	-24	-25	0	-1	-23	-44
EBITDA	-10	-12	-10	-10	-24	0	1	-23	-35
Interest Expense	-	-	-	3	-	-	8	-	8
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-17	-27	-15	-33	-28	-5	-11	-21	-46
Income Tax Expense	-1	-1	0	-3	0	0	0	0	0
Net Income	-18	-27	-15	-32	-30	-5	-11	-21	-46
Net Profit Margin	-2497.44%	-3966.44%	-890.17%	-1780.33%	-853.29%	-35.25%	-35.25%	-235.46%	221.36%

Nanobiotix Sa - Adr Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	1	0	0	0	0	0	5	39	-12
Gross Profit	0	1	0	0	0	0	0	4	39	-12
Operating Income	-17	-21	-25	-30	-46	-36	-52	-46	-26	-68
EBITDA	-16	-21	-25	-29	-44	-31	-45	-45	-23	-58
Interest Expense	0	0	0	0	4	0	0	5	7	8
Depreciation	-	-	0	0	1	1	1	1	1	1
Income Before Tax	-17	-21	-26	-30	-50	-33	-46	-57	-39	-68
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-18	-23	-30	-34	-56	-40	-53	-60	-43	-71
Net Profit Margin	-6403.14%	-1404.31%	-10375.62%	-25772.41%	-74875.00%	-67246.00%	-470040.00%	-1194.37%	-109.64%	586.89%

Nanobiotix Sa - Adr Quarterly Cash Flow

All numbers in Millions USD

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Mar 2025
Net Income	-15	-15	-30	-28	-5	-5	-11	-21	-46
Operating Cash Flow	-9	-9	-20	-17	2	-	4	-5	-13
Investing Cash Flow	0	0	0	0	-	-	0	0	0
Financing Cash Flow	-1	-1	-1	-1	24	-	48	-2	-2
Change in Cash	-10	-10	-24	-16	26	-	53	-4	54

Nanobiotix Sa - Adr Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-21	-26	-30	-50	-33	-47	-57	-39	-68
Operating Cash Flow	-18	-21	-25	-41	-27	-29	-37	-12	-19
Investing Cash Flow	0	-1	0	-1	0	0	0	0	0
Financing Cash Flow	22	48	14	41	111	-5	-5	46	-5
Change in Cash	4	26	-11	-1	84	-35	-42	33	-25

Global Institutional Holdings in Nanobiotix Sa - Adr

Funds	Holdings
Johnson & Johnson	11.74%
Perceptive Advisors LLC	0.22%
Jane Street Group LLC	0.02%
Geode Capital Management, LLC	0.02%
Morgan Stanley - Brokerage Accounts	0.01%

See all

Insights on Nanobiotix Sa - Adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NBTX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, NBTX stock has moved up by 102.6%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, NBTX has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -5.80M → -46.26M (in $), with an average decrease of 100.0% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 32.91M → -20.89M (in $), with an average decrease of 198.4% per quarter

About Nanobiotix Sa - Adr

nanobiotix (euronext: nano / isin: fr0011341205) is a late clinical-stage nanomedicine company pioneering novel approaches for the treatment of cancer. the company’s first-in-class, proprietary technology, nanoxray, enhances radiotherapy energy with a view to providing a new, more efficient treatment for cancer patients. nanoxray products are compatible with current radiotherapy treatments and are meant to treat potentially a wide variety of solid tumors including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, etc., via multiple routes of administration. nbtxr3 is being evaluated in: soft tissue sarcoma (sts), head and neck cancers, prostate cancer, and liver cancers (primary and metastases). additionally, head and neck cancer and rectal cancer trials led by nanobiotix’s taiwanese partner, pharmaengine, are underway in the asia pacific region. the company started a new preclinical research program in immuno-oncology with its lea

Organisation	Nanobiotix Sa - Adr
Headquarters	60 rue de Wattignies, Paris, France, 75012
Industry	Healthcare
CEO	Mr. Laurent Levy Ph.D.
E-voting on shares	Click here to vote

Key Management of Nanobiotix Sa - Adr

Name	Title
Dr. Leonard A. Farber M.D.	Chief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory Board
Mr. Laurent Levy Ph.D.	Co-Founder, President of the Executive Board & CEO
Mr. Bart Van Rhijn	Chief Financial & Business Officer and Member of Executive Board
Ms. Anne-Juliette Hermant M.A.	Chief People Officer & Member of Executive Board
Dr. Louis Kayitalire M.D.	Chief Medical Officer & Member of Executive Board
Mr. Earl J. Bergey Ph.d.	Co-Founder
Mr. Brandon Owens	VP of Strategic Marketing & Corporate Communication
Ms. Margaret Galluzzi	VP & Global Head of Clinical Operations

FAQs

What is Nanobiotix Sa - Adr share price today?

Nanobiotix Sa - Adr share price today is $9.74 as on September 17, 2025 at 1:29 am IST at the close of the market. Nanobiotix Sa - Adr share today touched a day high of $10.22 and a low of $9.72.

What is the 52 week high and 52 week low for Nanobiotix Sa - Adr share?

Nanobiotix Sa - Adr share touched a 52 week high of $10.59 on August 22, 2025 and a 52 week low of $2.76 on December 5, 2024. Nanobiotix Sa - Adr stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $9.74,which is 8.03% down from its 52 week high and 252.90% up from its 52 week low.

What is Nanobiotix Sa - Adr's market capitalisation today?

Nanobiotix Sa - Adr market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Nanobiotix Sa - Adr Stock (NBTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nanobiotix Sa - Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nanobiotix Sa - Adr Shares that will get you 0.1540 shares as per Nanobiotix Sa - Adr share price of $9.74 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Nanobiotix Sa - Adr Stock (NBTX) from India?

Indian investors can start investing in Nanobiotix Sa - Adr (NBTX) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 9:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Nanobiotix Sa - Adr stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 9:41 am IST). Based on Nanobiotix Sa - Adr share’s latest price of $9.74 as on September 17, 2025 at 1:29 am IST, you will get 1.0267 shares of Nanobiotix Sa - Adr. Learn more about fractional shares .